Peter Greenleaf
Director · Pelthos Therapeutics Inc.
- 2025
- Oct 6, 2026
- 7
Summary
Latest filing:
Peter Greenleaf is Director of Pelthos Therapeutics Inc. (PTHS). 7 SEC Form 4 filings on record going back to 2025, most recently on 6 October 2026. Most recent open-market trade: sold $17K of PTHS on 6 October 2026. Lifetime open-market sales: $54K.
Recent transactions
9The latest 9 SEC Form 4 transactions reported by Peter Greenleaf.
Trading pattern
InsiderAlpha's records for Peter Greenleaf go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. 5 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter Greenleaf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Davis - $1000K in PTHS purchases and sales in the last 12 months
- Ezra M. Friedberg - $326K in PTHS purchases and sales in the last 12 months
- Matthew Pauls - $54K in PTHS purchases and sales in the last 12 months
- Knuettel Francis II - $40K in PTHS purchases and sales in the last 12 months
- Richard Malamut - $12K in PTHS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter Greenleaf?
Peter Greenleaf is a corporate insider, tracked as Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter Greenleaf submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter Greenleaf been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($54K) across all tracked filings.